| STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125 | ||
|---|---|---|
| PDB id | Source | Resolution |
| 2WIH | 2.5 angstroms | |
| STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125 | ||
|---|---|---|
| PDB id | Source | Resolution |
| 2WIH | 2.5 angstroms | |
IDENTIFICATION OF N,1,4,4-TETRAMETHYL-8-{[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]AMINO}-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H]QUINAZOLINE-3-CARBOXAMIDE (PHA-848125), A POTENT, ORALLY AVAILABLE CYCLIN DEPENDENT KINASE INHIBITOR. J.MED.CHEM. V. 52
The Class containing this family consists of a total of 5 families. |
||
| Leader: | 2BPM |
|
|---|---|---|
| PDB id | Binding data | Representative ligand |
| 2BPM | ic50 = 2.0 nM | 529 |
| 1E9H | ic50 = 35.0 nM | INR |
| 1FIN | ATP | |
| 1H1P | Ki = 12.0 uM | CMG |
| 1H1Q | ic50 = 1.0 uM | 2A6 |
| 1H1R | ic50 = 2.3 uM | 6CP |
| 1H1S | Ki = 6.0 nM | 4SP |
| 1H24 | Kd = 0.5 uM | PRO-VAL-LYS-ARG-ARG-LEU-ASP-LEU-GLU |
| 1OI9 | ic50 = 69.0 nM | N20 |
| 1OIU | ic50 = 0.21 uM | N76 |
| 1OIY | ic50 ~ 64.0 nM | N41 |
| 1OKV | ic50 = 0.68 uM | ARG-ARG-LEU-ILE-PHE-NH2 |
| 1OKW | ic50 = 5.6 uM | ACE-ARG-ARG-LEU-ASN-FCL-NH2 |
| 1P5E | TBS | |
| 1PKD | UCN | |
| 1QMZ | HIS-HIS-ALA-SER-PRO-ARG-LYS | |
| 1VYW | ic50 = 37.0 nM | 292 |
| 2C5N | ic50 = 0.22 uM | CK8 |
| 2C5O | ic50 = 6.5 uM | CK2 |
| 2CJM | ATP | |
| 2G9X | ic50 = 45.0 nM | NU5 |
| 2IW6 | ic50 = 0.14 uM | QQ2 |
| 2IW8 | ic50 = 103.0 nM | 4SP |
| 2IW9 | ic50 = 8.9 nM | 4SP |
| 2UUE | ic50 = 1.3 uM | ARG-LEU-ILE-PFF-NH2-GVC |
| 2UZE | ic50 = 48.0 uM | C95 |
| 2UZL | ic50 = 0.61 uM | C94 |
| 2WEV | ic50 = 30.0 uM | ACE-ARG-ARG-B3L-MEA-NH2 |
| 2WIH | ic50 = 0.045 uM | P48 |
| 3BHT | ic50 = 0.011 uM | MFR |
| 3BHU | ic50 = 0.0030 uM | MHR |
| 3BHV | ic50 = 0.08 uM | VAR |
| 3DDQ | ic50 ~ 28.0 uM | RRC |
| 3F5X | ic50 = 1040.0 nM | EZV |
| 3MY5 | ic50 = 65.0 uM | RFZ |
| 3QHR | ADP | |
| 3QHW | ADP | |